drugset / Trial / NCT00320203
Anecortave Acetate in Patients With Open-angle Glaucoma
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, efficacy, and duration of effect of a single administration of Anecortave Acetate Depot for treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.
Timeline
- Start
- 2006-03
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Small molecule | 3 mg | Other |
| Subject | Anecortave Acetate | Small molecule | 15 mg | Other |
| Subject | Anecortave Acetate | Small molecule | 30 mg | Other |